The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: a proof-of-concept randomized controlled crossover trial

BACKGROUND: Patients with fibrotic interstitial lung disease (FILD) often experience gas exchange abnormalities and ventilatory limitations, resulting in reduced exercise capacity. High-flow nasal cannula (HFNC) oxygen therapy is a novel treatment, whose physiological beneficial effects have been de...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Pulm Med
Hoofdauteurs: Suzuki, Atsushi, Ando, Masahiko, Kimura, Tomoki, Kataoka, Kensuke, Yokoyama, Toshiki, Shiroshita, Eiichi, Kondoh, Yasuhiro
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7041255/
https://ncbi.nlm.nih.gov/pubmed/32093665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-020-1093-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items